obese. We also found a decrease in FEV1 comparing the 3 groups with a P , .011 morbid versus eutrophic and P , .049 morbid versus obese. Conclusions: Our results confirm the findings of others, who have shown that lung volumes especially FRC and ERV decrease as body weight increases. Obese patients have a combination of mechanical and inflammatory effects that result in pulmonary disability.
Oncology Unit, 3rd Department of Medicine, Sotiria General Hospital, Athens School of Medicine, Athens, Greece. Background: Lung cancer remains the leading cause of cancer-related deaths among men and women in the civilized world. A notable number of patients undergo radiation in various stages of the treatment process and its main respiratory side effect is pneumonitis. Our aim was to investigate the diagnostic and treatment methods of post-radiation pneumonitis particularly in asthma patients. Methods: A literature search was performed in Pubmed to identify relative studies published until June 2011. Lung cancer, post-radiation pneumonitis, therapy and asthma were the key words used for the search. Results: Post-radiation pneumonitis is a clinical situation demanding early diagnosis in asthma patients, but the latter is often underestimated. Pneumonitis is clinically revealed by dyspnea, cough, fever and usually begins up to 12 weeks after the start of radiation treatment. Radiographically, it appears as diffuse or patchy consolidation and/or ground glass opacities. Pulmonary function decline is correlated to decreased values of forced expiratory volume in the 1st second (FEV1) and diffusing capacity of the lung for carbon monoxide (DLCO). The effects on normal tissue may mimic or hide tumor recurrence. Smoking cessation causes changes of total lung capacity and vital capacity and this may have consequences on lung volume results in dose volume histogram analysis, targeting precision, oxygenation changes, tumor biology (gene expression) and prognosis. NCI Common Toxicity Criteria (CTC) V3.0 assessments are usually preformed weekly during radiotherapy and at regular follow-up visits. Complication rates vary with dose, fractionation, schedule duration, technique, photons' energy, irradiated volume, dose escalation, accelerated fractionation schemes, fields, co-morbidities and concurrent chemo-radiotherapy. Conclusions: The crucially deteriorating on therapy effect of pneumonitis leads to the realization that alertness and constant attention is not only strongly advised, but compulsory in asthma patients. 2 Department of Allergy, Sotiria General Hospital, Athens, Greece, Athens, Greece. Background: Chest radiation is a common therapeutic approach in the management of lung cancer, as well as in other malignancies, rendering radiationinduced pneumonitis a rather commonly reported adverse event. A large proportion of patients undergoing radiation have underlying chronic obstructive pulmonary disease (COPD). We aim to elucidate the pathogenetic pathways implicated in radiation-induced pneumonitis particularly in this subgroup of patients. Methods: A literature search was performed in PubMed to identify relative studies published until June 2011. Results: The incidence of radiation-induced pneumonitis after conventional irradiation in COPD is about 7 to 10% in the moderate although symptomatic forms and about 1 to 3% in the severe forms. Radiation-induced pneumonitis seems to be an acute-phase reaction, taking primarily place in the most radiosensitive subunit of the lung, the alveolar/capillary complex. Reactive oxygen species, generated by radiation, initiate a cascade of molecular events that alter the cytokine milieu of the microenvironment, creating inflammation and chronic oxidative stress. COPD is characterized by a chronic inflammatory state in the lung, also generating reactive oxidant species. Biological markers intrinsic to the patient, such as early variations of certain cytokines (IL-6, IL-10, TGF-b) seem to be implicated and studies are under way to determine their role. The standard dose-volume metrics, such as V20, V13 and mean lung dose, are major factors influencing the clinical course of radiation-induced pneumonitis. Conclusions: Understanding the underlying pathogenesis of radiationinduced pneumonitis may help improve optimal delivery of treatment plans, minimize the risks and increasing the therapeutic ratio in patients with COPD. 
